Dr. Mary Dwyer, PhD

Director at Antharis Therapeutics

Speaker

Mary Dwyer, PhD, is a scientific director with over 15 years of expertise in biologics drug discovery, specializing in antibody platforms and multi-specific formats. She has led groundbreaking initiatives, including establishing VHH discovery platforms and directing over 20 therapeutic antibody programs, two of which reached clinical trials. Her leadership spans immune-oncology and viral glycoprotein targets, pioneering novel screening techniques and integrating advanced technologies like Fc engineering. With a strong track record in team mentoring and project success, Mary has made significant contributions to biochemistry and immunology across roles at Eitr Biologics, AlivaMab Discovery Services, Abcore Inc., Celgene Inc., and currently Antharis Therapeutics.